These results are consistent with preclinical data showing that RB1 knockdown or functional inactivation in prostate cancer cells inhibits the androgen deprivation-induced proliferative stall [49, 109] and is sufficient to induce castration-resistant tumor xenograft growth [108]. This evidence concerns the gene RB1 and Familial prostate cancer.